Chinese E-cigarette Exports to Japan: December 2023 Statistics

Industry Insight by 2FIRSTS Mincy
Feb.06.2024
Chinese E-cigarette Exports to Japan: December 2023 Statistics
China's e-cigarette exports to Japan in December 2023 reached $20.64 million, with a 55.5% monthly increase but a 53.17% annual decrease.

According to the updated trade data from the General Administration of Customs of the People's Republic of China, 2FIRSTS has compiled the e-cigarette export figures from China to Japan in December 2023 as follows:

Chinese E-cigarette Exports to Japan: December 2023 Statistics
Image source: 2FIRSTS (Mincy graphic)

 

The export volume amounted to approximately 20.64 million US dollars, marking a month-on-month increase of 55.5% and a year-on-year decrease of 53.17%.

Chinese E-cigarette Exports to Japan: December 2023 Statistics
Image source: 2FIRSTS (created by Mincy)

 

The export volume is approximately 115 tons, with a month-on-month growth of 26.02% but a year-on-year decline of 61.11%.

Chinese E-cigarette Exports to Japan: December 2023 Statistics
Image source: 2FIRSTS (created by Mincy)

 

The export unit price is $179.85 per kilogram, showing a quarter-on-quarter growth of 23.4% and a year-on-year increase of 20.42%. The average price for "e-cigarettes and similar personal electronic vaporizers" is $36.92 per unit.

Chinese E-cigarette Exports to Japan: December 2023 Statistics
Image source: 2FIRSTS (Chart by Mincy)

 

Among them, "e-cigarettes and similar personal electronic vaporizers" account for 0.12% of the export category, while "non-combustible products without tobacco or reconstituted tobacco that contain nicotine for inhalation" account for 99.88% of the total.

Chinese E-cigarette Exports to Japan: December 2023 Statistics
Image source: 2FIRSTS (Mincy Design)

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | Following the discontinuation of the AF5000, ELFBAR launches compliant alternative AF5500 in the UK.
Product | Following the discontinuation of the AF5000, ELFBAR launches compliant alternative AF5500 in the UK.
ELFBAR has launched the AF5500 in the UK, featuring a 12ml e-liquid capacity. Both its appearance and naming are similar to the popular "2+10" product, the AF5000, which was previously a bestseller in the region. The AF5000 has been removed from the market due to the disposable vape ban, and the AF5500 is likely to be its compliant alternative.
Sep.05 by 2FIRSTS.ai
Ukraine Busts Illegal E-Liquid Production Site, Seizing Over 5 Tons of Finished Product and Inputs
Ukraine Busts Illegal E-Liquid Production Site, Seizing Over 5 Tons of Finished Product and Inputs
Ukraine’s Bureau of Economic Security (BEB) dismantled an illegal e-liquid production site in Dnipropetrovsk Oblast, seizing more than five tons of liquids and related equipment. Two residents of Kryvyi Rih were notified of suspicion for “illegal manufacture, storage, transportation, and sale of excisable goods committed by a group upon prior conspiracy.” The case is being advanced jointly by the National Police and the Office of the Prosecutor General.
Sep.03 by 2FIRSTS.ai
Tunisia's tobacco control policies are insufficiently implemented; experts call for the introduction of less harmful alternatives to help quit smoking
Tunisia's tobacco control policies are insufficiently implemented; experts call for the introduction of less harmful alternatives to help quit smoking
Although Tunisia has joined the WHO Framework Convention on Tobacco Control and implemented policies such as smoking bans and advertising restrictions, insufficient enforcement means nearly half of all men still smoke, with youth being particularly vulnerable. Public health experts recommend that Tunisia learn from the experiences of Sweden and the United Kingdom, introduce less harmful alternatives, and establish a customized regulatory system.
Sep.30 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Kazakh Man Fined $146 for Illegal Sale of e-cigarettes in Uralsk
Kazakh Man Fined $146 for Illegal Sale of e-cigarettes in Uralsk
A man in Ural'sk, Kazakhstan, was fined 78,640 tenge (about 146 US dollars) for illegal e-cigarette sales. The police took swift action after the case was exposed.
Aug.22 by 2FIRSTS.ai
Alan Zhao | Compliance, Innovation, and the Industry Shake-up: Lessons from Smoore’s 2025 Mid-Year Report
Alan Zhao | Compliance, Innovation, and the Industry Shake-up: Lessons from Smoore’s 2025 Mid-Year Report
In his analysis of Smoore’s 2025 mid-year report, Alan Zhao notes that U.S. enforcement and Europe’s bans are accelerating industry shake-ups, making compliance capability the dividing line for survival. He argues that Smoore’s strategy has shifted from “understanding” to “executing,” and that the next 12–18 months will be not only a critical transition period for the company but also a decisive stage in reshaping the global vapor industry landscape.
Aug.25